Industry Insight
Information, Observation & Analysis
Therapeutics Articles
For decades, donor blood stem cell transplantation has been the only potential cure for severe primary immunodeficiency disorders, but it has been limited by failure and serious complication risks. Now, a trifecta of scientific advances is transforming the prognosis for children once defenseless against life-threatening infections.
Healthcare industry stakeholders are increasingly using diagnosis-specific apps and educational gaming platforms to engage with patients, encourage compliance and even manage treatment options.
Treatment advances over the past 40 years have transformed the lives of people with hemophilia, and more innovation lies ahead.
Thanks to breakthroughs in genome sequencing, personalized medicine is rapidly becoming more science than fiction. As experimental therapies are replaced with data-driven solutions, we may be closer than ever to the kind of patient-specific care that promises to revolutionize the way medicine is practiced.
While all IG products are comparably effective, they also have relevant differences that determine their tolerability by patients.
Until better treatments or a cure can be found, coagulation factor replacement therapies continue to improve the long-term outcome for people with bleeding disorders
Scientific breakthroughs using gene therapy are allowing physicians to take a “precision medicine” approach to treating cancer — with promising results.
Hospital-acquired infections remain a deadly threat, but the Centers for Disease Control and Prevention in partnership with other healthcare agencies and professionals are working to lower the rates of HAIs with some degree of success.
For resuscitation of patients with sepsis, the verdict is in: Hydroxyethyl starch products increase the risk of acute kidney injury and death.
6% hydroxyethyl starch products have been touted as a less-expensive alternative to 5% human albumin for blood volume expansion, but recent published evidence shows that it comes at a price for selected populations.
With the rising rates of autoimmune disease, the quest is on to research and develop new medicines to treat patients who often present with multiple disorders.